| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 18.14% | Morgan Stanley | $40 → $41 | Maintains | Overweight |
| 11/09/2023 | 23.9% | BMO Capital | $42 → $43 | Maintains | Outperform |
| 10/02/2023 | 21.02% | BMO Capital | $40 → $42 | Maintains | Outperform |
| 09/21/2023 | 6.61% | B of A Securities | $31 → $37 | Maintains | Buy |
| 09/21/2023 | 15.26% | Morgan Stanley | $35 → $40 | Maintains | Overweight |
| 08/23/2023 | 0.85% | Morgan Stanley | $33 → $35 | Maintains | Overweight |
| 08/10/2023 | 15.26% | BMO Capital | $37 → $40 | Maintains | Outperform |
| 07/21/2023 | -4.91% | Morgan Stanley | $32 → $33 | Maintains | Overweight |
| 06/23/2023 | -7.79% | Morgan Stanley | $31 → $32 | Maintains | Overweight |
| 05/22/2023 | -10.68% | Morgan Stanley | $32 → $31 | Maintains | Overweight |
| 05/03/2023 | -7.79% | Morgan Stanley | $31 → $32 | Maintains | Overweight |
| 03/21/2023 | -10.68% | Morgan Stanley | $30 → $31 | Maintains | Overweight |
| 03/07/2023 | 0.85% | BMO Capital | $32 → $35 | Maintains | Outperform |
| 02/22/2023 | -13.56% | Morgan Stanley | $31 → $30 | Maintains | Overweight |
| 11/11/2022 | -10.68% | Morgan Stanley | $32 → $31 | Maintains | Overweight |
| 10/21/2022 | -7.79% | Morgan Stanley | $33 → $32 | Maintains | Overweight |
| 08/23/2022 | -4.91% | Morgan Stanley | $32 → $33 | Maintains | Overweight |
| 07/29/2022 | -7.79% | Morgan Stanley | $31 → $32 | Maintains | Overweight |
| 05/23/2022 | -10.68% | Morgan Stanley | $30 → $31 | Maintains | Overweight |
| 09/01/2021 | -22.2% | Morgan Stanley | $25 → $27 | Maintains | Overweight |
| 08/19/2021 | -27.96% | Morgan Stanley | $27 → $25 | Maintains | Overweight |
| 07/22/2021 | — | Guggenheim | Upgrades | Neutral → Buy | |
| 07/09/2021 | -33.73% | B of A Securities | → $23 | Upgrades | Neutral → Buy |
| 07/07/2021 | -27.96% | Wolfe Research | → $25 | Upgrades | Peer Perform → Outperform |
| 06/21/2021 | -22.2% | Morgan Stanley | $28 → $27 | Maintains | Overweight |
| 06/03/2021 | -33.73% | Credit Suisse | $26 → $23 | Maintains | Outperform |
| 04/27/2021 | -19.32% | Morgan Stanley | $30 → $28 | Maintains | Overweight |
| 04/20/2021 | -13.56% | Morgan Stanley | $29 → $30 | Maintains | Overweight |
| 03/19/2021 | -16.44% | Morgan Stanley | $28 → $29 | Maintains | Overweight |
| 03/17/2021 | — | Guggenheim | Downgrades | Buy → Neutral | |
| 03/17/2021 | -42.37% | Wolfe Research | $24 → $20 | Downgrades | Outperform → Peer Perform |
| 03/15/2021 | -33.73% | RBC Capital | $25 → $23 | Maintains | Outperform |
| 03/08/2021 | -19.32% | Morgan Stanley | $33 → $28 | Maintains | Overweight |
| 03/01/2021 | -27.96% | Credit Suisse | $32 → $25 | Reiterates | → Outperform |
| 02/18/2021 | -4.91% | Morgan Stanley | $34 → $33 | Maintains | Overweight |
| 12/15/2020 | -2.03% | Morgan Stanley | $32 → $34 | Maintains | Overweight |
| 11/17/2020 | -7.79% | Morgan Stanley | $34 → $32 | Maintains | Overweight |
| 11/04/2020 | -2.03% | Morgan Stanley | $33 → $34 | Maintains | Overweight |
| 10/20/2020 | -4.91% | Morgan Stanley | $34 → $33 | Maintains | Overweight |
| 07/17/2020 | -2.03% | Morgan Stanley | $35 → $34 | Maintains | Overweight |
| 06/17/2020 | 0.85% | Morgan Stanley | $34 → $35 | Maintains | Overweight |
| 06/09/2020 | — | Seaport Global | Upgrades | Neutral → Buy | |
| 05/20/2020 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 05/06/2020 | -10.68% | UBS | $34 → $31 | Maintains | Buy |
| 04/30/2020 | -2.03% | Morgan Stanley | $35 → $34 | Maintains | Overweight |
| 04/15/2020 | 0.85% | Morgan Stanley | $36 → $35 | Maintains | Overweight |
| 02/25/2020 | 3.73% | Vertical Research | → $36 | Initiates Coverage On | → Buy |
| 02/20/2020 | 6.61% | BMO Capital | → $37 | Initiates Coverage On | → Outperform |
| 11/07/2019 | -10.68% | B of A Securities | → $31 | Upgrades | Neutral → Buy |
| 09/17/2019 | -10.68% | SunTrust Robinson Humphrey | $30 → $31 | Maintains | Buy |
| 08/29/2019 | -7.79% | Citigroup | $31 → $32 | Maintains | Buy |
| 08/14/2019 | -10.68% | Credit Suisse | $30 → $31 | Maintains | Outperform |
| 05/06/2019 | -7.79% | Credit Suisse | $26 → $32 | Upgrades | Neutral → Outperform |
| 04/11/2019 | 3.73% | Citigroup | $32 → $36 | Maintains | Buy |
| 03/25/2019 | 0.85% | Morgan Stanley | → $35 | Initiates Coverage On | → Overweight |
What is the target price for Vistra (VST)?
The latest price target for Vistra (NYSE: VST) was reported by Morgan Stanley on November 21, 2023. The analyst firm set a price target for $41.00 expecting VST to rise to within 12 months (a possible 18.14% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vistra (VST)?
The latest analyst rating for Vistra (NYSE: VST) was provided by Morgan Stanley, and Vistra maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Vistra (VST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vistra, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vistra was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Vistra (VST) correct?
While ratings are subjective and will change, the latest Vistra (VST) rating was a maintained with a price target of $40.00 to $41.00. The current price Vistra (VST) is trading at is $34.71, which is out of the analyst's predicted range.